IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 14 filers reported holding IBERE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $649 | -99.9% | 64,980 | 0.0% | 0.01% | +28.6% |
| Q3 2022 | $644,000 | +0.9% | 64,980 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $638,000 | -0.5% | 64,980 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $641,000 | -1.5% | 64,980 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $651,000 | +0.3% | 64,980 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $649,000 | -0.6% | 64,980 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $653,000 | +2.0% | 64,980 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $640,000 | – | 64,980 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |